Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Operating Leases (2020 - 2023)

Updated

Analysis

Grace Therapeutics (GRCE) Operating Leases (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 410,000.00
Dec 31, 2022 430,000.00
Sep 30, 2022 450,000.00
Jun 30, 2022 174,000.00
Mar 31, 2022 191,000.00
Dec 31, 2021 22,000.00
Sep 30, 2021 43,000.00
Jun 30, 2021 66,000.00
Mar 31, 2021 86,000.00
Dec 31, 2020 105,000.00
Sep 30, 2020 38,000.00
Jun 30, 2020 56,000.00
Mar 31, 2020 71,000.00
API Access

Grace Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=GRCE&period=max&api_key=YOUR_API_KEY